Literature DB >> 31173961

Improving our understanding of metal implant failures: Multiscale chemical imaging of exogenous metals in ex-vivo biological tissues.

Alexander P Morrell1, Hayley Floyd2, J Frederick W Mosselmans3, Liam M Grover2, Hiram Castillo-Michel4, Edward T Davis5, Julia E Parker3, Richard A Martin6, Owen Addison7.   

Abstract

Biological exposures to micro- and nano-scale exogenous metal particles generated as a consequence of in-service degradation of orthopaedic prosthetics can result in severe adverse tissues reactions. However, individual reactions are highly variable and are not easily predicted, due to in part a lack of understanding of the speciation of the metal-stimuli which dictates cellular interactions and toxicity. Investigating the chemistry of implant derived metallic particles in biological tissue samples is complicated by small feature sizes, low concentrations and often a heterogeneous speciation and distribution. These challenges were addressed by developing a multi-scale two-dimensional X-ray absorption spectroscopic (XAS) mapping approach to discriminate sub-micron changes in particulate chemistry within ex-vivo tissues associated with failed CoCrMo total hip replacements (THRs). As a result, in the context of THRs, we demonstrate much greater variation in Cr chemistry within tissues compared with previous reports. Cr compounds including phosphate, hydroxide, oxide, metal and organic complexes were observed and correlated with Co and Mo distributions. This variability may help explain the lack of agreement between biological responses observed in experimental exposure models and clinical outcomes. The multi-scale 2D XAS mapping approach presents an essential tool in discriminating the chemistry in dilute biological systems where speciation heterogeneity is expected. SIGNIFICANCE: Metal implants are routinely used in healthcare but may fail following degradation in the body. Although specific implants can be identified as 'high-risk', our analysis of failures is limited by a lack of understanding of the chemistry of implant metals within the peri-prosthetic milieu. A new approach to identify the speciation and variability in speciation at sub-micron resolution, of dilute exogenous metals within biological tissues is reported; applied to understanding the failure of metallic (CoCrMo) total-hip-replacements widely used in orthopedic surgery. Much greater variation in Cr chemistry was observed compared with previous reports and included phosphate, hydroxide, oxide, metal and organic complexes. This variability may explain lack of agreement between biological responses observed in experimental exposure models and clinical outcomes.
Copyright © 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CoCr chemistry; Metal particle chemistry; Microfocus spectroscopy; Total hip replacement; XANES mapping; XRF

Mesh:

Substances:

Year:  2019        PMID: 31173961     DOI: 10.1016/j.actbio.2019.05.071

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  3 in total

1.  Synchrotron-based characterization of arthroprosthetic CoCrMo particles in human bone marrow.

Authors:  Janosch Schoon; Bernhard Hesse; Remi Tucoulou; Sven Geissler; Melanie Ort; Georg N Duda; Carsten Perka; Georgi I Wassilew; Giorgio Perino; Anastasia Rakow
Journal:  J Mater Sci Mater Med       Date:  2022-06-13       Impact factor: 4.727

2.  The quintessence of metallomics: a harbinger of a different life science based on the periodic table of the bioelements.

Authors:  Wolfgang Maret
Journal:  Metallomics       Date:  2022-08-25       Impact factor: 4.636

Review 3.  The contribution of the histopathological examination to the diagnosis of adverse local tissue reactions in arthroplasty.

Authors:  Giorgio Perino; Ivan De Martino; Lingxin Zhang; Zhidao Xia; Jiri Gallo; Shonali Natu; David Langton; Monika Huber; Anastasia Rakow; Janosch Schoon; Enrique Gomez-Barrena; Veit Krenn
Journal:  EFORT Open Rev       Date:  2021-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.